Literature DB >> 25594889

Genetic and epigenetic basis of psoriasis pathogenesis.

Aditi Chandra1, Aditi Ray1, Swapan Senapati2, Raghunath Chatterjee3.   

Abstract

Psoriasis is a chronic inflammatory skin disease whose prevalence varies among different populations worldwide. It is a complex multi-factorial disease and the exact etiology is largely unknown. Family based studies have indicated a genetic predisposition; however they cannot fully explain the disease pathogenesis. In addition to genetic susceptibility, environmental as well as gender and age related factors were also been found to be associated. Recently, imbalances in epigenetic networks are indicated to be causative elements in psoriasis. The present knowledge of epigenetic involvement, mainly the DNA methylation, chromatin modifications and miRNA deregulation is surveyed here. An integrated approach considering genetic and epigenetic anomalies in the light of immunological network may explore the pathogenesis of psoriasis.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA methylation; Generalized plaque type psoriasis; Genome-wide association study; Histone modifications; Micro RNA; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2015        PMID: 25594889     DOI: 10.1016/j.molimm.2014.12.014

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  46 in total

1.  MiR-548a-3p Promotes Keratinocyte Proliferation Targeting PPP3R1 after Being Induced by IL-22.

Authors:  Xintong Zhao; Ronghua Li; Meng Qiao; Jianjun Yan; Qing Sun
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

2.  Association of IL12B risk haplotype and lack of interaction with HLA-Cw6 among the psoriasis patients in India.

Authors:  Aditi Chandra; Swapan Senapati; Saurabh Ghosh; Gobinda Chatterjee; Raghunath Chatterjee
Journal:  J Hum Genet       Date:  2016-11-10       Impact factor: 3.172

3.  Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients.

Authors:  F D'Amico; M Granata; E Skarmoutsou; C Trovato; G Lovero; P Gangemi; V Longo; M Pettinato; M C Mazzarino
Journal:  Inflamm Res       Date:  2018-03-31       Impact factor: 4.575

4.  Psoriasis patients demonstrate HLA-Cw*06:02 allele dosage-dependent T cell proliferation when treated with hair follicle-derived keratin 17 protein.

Authors:  Milyausha Yunusbaeva; Ruslan Valiev; Fanil Bilalov; Zilya Sultanova; Leyla Sharipova; Bayazit Yunusbayev
Journal:  Sci Rep       Date:  2018-04-17       Impact factor: 4.379

5.  Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: A cohort study.

Authors:  Alanna C Bridgman; Abrar A Qureshi; Tricia Li; Fred K Tabung; Eunyoung Cho; Aaron M Drucker
Journal:  J Am Acad Dermatol       Date:  2019-02-21       Impact factor: 11.527

Review 6.  Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature.

Authors:  Brahim Azzouz; Aurore Morel; Lukshe Kanagaratnam; Emmanuelle Herlem; Thierry Trenque
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

7.  Chronic tophaceous gout in patients with psoriasis.

Authors:  Laís Cruz Lobato; Jéssica Castiel Coutinho; Maria Zeli Moreira Frota; Antonio Pedro Mendes Schettini; Mônica Santos
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

8.  miR-617 Promotes the Growth of IL-22-Stimulated Keratinocytes Through Regulating FOXO4 Expression.

Authors:  Tao Liu; Xiaomei Feng; Yongmei Liao
Journal:  Biochem Genet       Date:  2020-11-19       Impact factor: 1.890

Review 9.  The Inflammatory Response in Psoriasis: a Comprehensive Review.

Authors:  Yaxiong Deng; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 10.  Protein tyrosine phosphatase SHP-1: resurgence as new drug target for human autoimmune disorders.

Authors:  Yadhu Sharma; Samina Bashir; Puja Bhardwaj; Altaf Ahmad; Farah Khan
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.